-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_disposition-comments.pdf
May 04, 2015 - Disposition of Comments Report for Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie
Draft review available for public comme…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
May 01, 2012 - participate in the Women’s
Health Initiative randomized controlled trial were required to undergo a three-month
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
November 01, 2016 - Noninvasive Treatments for Low Back Pain: A Summary of the Research for Adults
Noninvasive Treatments
for Low Back Pain
A Summary of the Research for Adults
e
DRAFT: CONFIDENTIAL - For review only, not for dissemination - Task 3.7c- LowBackPain_consumer - Last mod on: 15-Nov-2016, 11:04
Archived: This
report i…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-200-post-acs-depression.pdf
November 01, 2017 - Diagnostic Accuracy of Screening and Treatment of Post–Acute Coronary Syndrome Depression: A Systematic Review. Evidence Summary.
Comparative Effectiveness Review
Number 200
Diagnostic Accuracy of Screening and Treatment
of Post–Acute Coronary Syndrome Depression: A
Systematic Review
Evidence Summary
Objective…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
December 01, 2015 - BWL
2 RCTs (N = 170) CBT decreased binge frequency more than BWL at end of
treatment and up to 12-month … )
and long-term (12 month) followup. … CBT was superior to BWL for decreasing binge
frequency at end of treatment and up to 12-month followup … Loss of control
over eating predicts outcomes in bariatric surgery patients: a
prospective, 24-month … Grilo CM, Wilson GT, Crosby RD, et al. 12-month follow-up
of fluoxetine and cognitive behavioral therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-protocol.pdf
February 18, 2023 - Long COVID Models of Care
Evidence-based Practice Center Technical Brief Protocol
Project Title: Long COVID Models of Care
I. Background and Objectives for the Technical Brief
A large, growing population of persons have experienced severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infectio…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-evidence-summary.pdf
January 01, 2020 - rates of breastfeeding for at least 3 months, and PedNSS measured rates of breastfeeding for at least 1 month … Quality of life of mothers at the sixth week and sixth month post
partum and type of infant feeding.
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Daily self-injection with teduglutide at the recommended dose of 0.05 mg/kg costs
about $30,000 per month … pharmacy identified a retail cost of about $30,000
for 30 single-injection vials of teduglutide—a 1-month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-G1-2.xlsx
January 01, 2022 - Table G-1. ROB RCTs
Table G-1. Risk of bias of cannabis RCTs
Author, Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Patient Masked? Care Provider Masked? Outcome Assessors Masked? Intention-To-Treat Analysis? Rate of Overall Attrition Within Acceptable Levels? Rate of Diffe…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-G.xlsx
January 01, 2023 - Table G-1. ROB RCTs
Table G-1. Risk of bias of cannabis RCTs
Author, Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Patient Masked? Care Provider Masked? Outcome Assessors Masked? Intention-To-Treat Analysis? Rate of Overall Attrition Within Acceptable Levels? Rate of Diffe…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-F1-F-2.xlsx
January 01, 2023 - Table F-1. ROB RCTs
Table F-1. Risk of bias of cannabis RCTs
Author, Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Patient Masked? Care Provider Masked? Outcome Assessors Masked? Intention-To-Treat Analysis? Rate of Overall Attrition Within Acceptable Levels? Rate of Diffe…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
December 01, 2009 - months13,14 have shown tiotropium improves lung function, symptoms and quality of life,
while a six-month … To be included patients had to have a COPD diagnosis (ICD-9 491.x, 492.x, 496)
during a twelve month … A 6-month, placebo-
controlled study comparing lung
function and health status changes in
COPD patients
-
effectivehealthcare.ahrq.gov/sites/default/files/celiac-disease_disposition-comments.pdf
January 28, 2016 - Disposition of Comments for CER 162 Diagnosis of Celiac Disease
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Diagnosis of Celiac Disease
Draft review available for public comment from January 29, 2015 to February 27, 2015.
Research Review Citation: Maglione MA, Okunogbe…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
July 18, 2011 - headaches accounted for 2.2 percent of visits or 2.1 million ED
visits per year.
9
In fact, a 5-month
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Alimera Sciences announces new 36-month
analysis that shows Iluvien slows diabetic
retinopathy progression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
January 27, 2012 - significant impairment or distress, as
manifested by at least 1 of the following occurring within a 12-month … or distress, as
manifested by at least 3 of the following occurring at any time in the same 12-month … endogenous opioids such as b-endorphin
Oral: 50 to 100 mg per day
Intramuscular injection: 380 mg per month … placebo-treated subjects.45,46 One study reported that
patients receiving injectable naltrexone 380 mg per month … Second, for
nalmefene, we found moderate SOE supporting efficacy
for reducing heavy drinking days per month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-disposition-comments.pdf
March 31, 2025 - Disposition of Comments_Systematic Review: Breastfeeding and Health Outcomes for Infants and Children
Systematic Review Disposition of Comments Report
Title: Breastfeeding and Health Outcomes for Infants and Children
Draft report was available for public comment from September 23 to October 23, 2024.
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
May 01, 2025 - In the first month, patients are mainly at risk of
candida, herpes simplex virus, and hospital-acquired … IIa, Level of Evidence:
C)"
In a sample follow up visit schedule, dental exam was included in 6-
month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
April 01, 2005 - Both
were of short
duration (1
6-month, 1
with main
analyses at 12
months, but
patients
followed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-executive-summary.pdf
April 01, 2025 - clinician support-
based implementation
approach has little to no
effect on risk behaviors
at 3-month … clinician support-
based implementation
approach probably has
little to no effect on risk
behaviors at 6-month